To confirm that laminar patterns were not influenced by concomitant pathology (Table 1), we excluded patients with any pathology secondary to FTLD-tau and FTLD-TDP, including low-to-high AD neuropathologic change (ADNC). Here, MAPT is linked to Alzheimer disease.